Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05349929
Other study ID # 1111
Secondary ID
Status Not yet recruiting
Phase Phase 2
First received
Last updated
Start date May 2022
Est. completion date December 2022

Study information

Verified date April 2022
Source Qazvin University Of Medical Sciences
Contact Mona Esfahani, Student
Phone +989120407509
Email monaes2424@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hypothesis: 0: The analgesic effect of Ibuprofen and Anahil would be the same in reducing the pain after root canal therapy. 1: Ibuprofen shows higher potency to reduce the pain after root canal therapy. 1: Anahil shows higher potency to reduce the pain after root canal therapy. 1. combination of the Anahil and Ibuprofen would have more effective results in reducing the pain post endodontic treatment.


Description:

Patients will be selected from those who are referred to receive root canal therapy for the mandibular first molars with irreversible pulpitis. The current research and all the procedures will be done in a private dental clinic in Qazvin, Iran by a single endodontist. 72 Patients who will meet our study demands and criteria would be qualified to enter the study and will sign the informed consent form explaining the study circumstances and its possible risks. Patient information sheet includes dental, medical and drug history and demographic information will be obtained as well. Radiographic examination includes the amount of caries, root curvature, periapical and hard tissue situation, dental pulp vitality tests including Electrical Pulp Test(EPT) and thermal tests (heat and cold) and periapical tests consisting of percussion and palpation would be recorded. The patients would be divided randomly in Ibuprofen and Anahil groups, these drugs would be put in the same shape and appearance by a pharmacist and named as A and B respectively. Anahil capsules containing 200 mg of bromelain, Permon-Amin Health Company, Gelofen 400mg capsules, Dana-Pharma company:The pre procedure pain of the patients would be asked and recorded by Visual Analogue Scale(VAS), a 100 mm long ruler which has no numeration by means of enhancing the accuracy and minimizing the failure. Standard Infra alveolar nerve(IAN) direct block will be done by injection of 1.8ml of lidocaine 2% containing 1:100000 epinephrine with a long 32mm gauge 27 needle. The efficiency of Inferior Alveolar Nerve block injection will be examined with the numbness of inferior lip. Supplementary anesthesia (like intrapulpal or Periodontal Ligament(PDL) anesthesia) will be used if the pain is still remained after 15 minutes. After tooth isolation with rubberdam, caries removal, access cavity and tooth preparation will be done. Length determination will be performed with the help of periapical radiography and apex locator. Cleaning and shaping will be done. Normal Saline and hypochlorite 2% will be used as intracanal irrigants. The canals will then be dried and gutted laterally with gutta-percha and AH+ sealer. A cotton pellet will be placed in the access cavity. Temporary restoration will be applied after occlusal reduction and the occlusion will be checked. No intracanal medicament will be placed. In this triple blinded study, patients will be given A and B drugs (36 patients in each group, equal in gender) with medications order randomly and will be followed 6, 12, 24 and 48 hours after endodontics treatment to report the pain score with VAS and the number of supplementary dosage of Ibuprofen with the time that they have consumed.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 72
Est. completion date December 2022
Est. primary completion date November 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria: 1. Patients report spontaneous pain of the first molar of mandible ranging from 50 to 100 mm on a VAS (0-100 mm) 2. The dental pulp's condition is irreversible pulpitis and the tooth is reparable and need the root canal therapy 3. No evidences of any lesions and lucency, PDL widening, loss of lamina dura in radiographic examination 4. Patients aged 20 to 50 years from both genders 5. Patients are not pregnant or breast-feeding 6. Healthy periodontal status (no evidences of aggressive/chronic periodontal diseases) 7. No history of any systemic diseases (specially gastrointestinal and coagulation disorders) 8. No history of allergic reaction to food nutrients (specially pineapple, celery, carrot, and fennel), NSAIDs and lidocaine 9. No history of consuming the drugs interfere with NSAIDs, lidocaine and anticoagulants 10. No use of other analgesic drugs within the last 6 hours 11. Existence of no large restorations or crowns in treated tooth 12. patients have no extreme fear of dental procedure 13. Teeth with no evidence of infection or sinus tract 14. Patients did not a previous RCT Exclusion Criteria: 1. Patients who leave the study because of any reasons 2. Special anatomy of teeth (extra canals, severe root curvature, calcifications, open apex, C shape, fractures,..) 3. Patients who are not able to tolerate the single-session treatment (time, tooth's situation,..) 4. If the aspiration through IAN block injection is positive 5. If the diagnosis of pulp status has changed to partial necrosis during access cavity preparation

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Gelofen (generic name of Ibuprofen in Iran)
Gelofen capsules, 400mg Ibuprofen, Dana pharma company, every 6hours
Anahil ( generic name of Bromelain in Iran)
Anahil capsules,200 mg Bromelain, Permon Amin Health Company,every 6hours
Procedure:
Root Canal Therapy
all the participants go under RCT.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Qazvin University Of Medical Sciences

Outcome

Type Measure Description Time frame Safety issue
Primary pain severity Visual Analogue Scale 0 hour (before root canal treatment)
Primary pain severity Visual Analogue Scale 6 hours after root canal treatment
Primary pain severity Visual Analogue Scale 12 hours after root canal treatment
Primary pain severity Visual Analogue Scale 24 hours after root canal treatment
Primary pain severity Visual Analogue Scale 48 hours after root canal treatment
Primary need of supplemental dosage of Ibuprofen By asking the numbers of consuming capsules 6 hours after root canal treatment
Primary need of supplemental dosage of Ibuprofen By asking the numbers of consuming capsules 12 hours after root canal treatment
Primary need of supplemental dosage of Ibuprofen By asking the numbers of consuming capsules 24 hours after root canal treatment
Primary need of supplemental dosage of Ibuprofen By asking the numbers of consuming capsules 48 hours after root canal treatment
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04585438 - Evaluation of Trans-mucosal Bio-adhesive Discs of Diclofenac Potassium on the Anesthetic Success and Postoperative Pain in Patients With Symptomatic Irreversible Pulpitis: A Randomized Clinical Trial Phase 4
Completed NCT02923687 - Premedication Efficacy of Ketorolac Infiltration on Post Endodontic Pain Phase 2
Completed NCT02614118 - Premedication Efficacy of Oral Ketorolac and Ketorolac/ Acetaminophen on Post Treatment Pain Phase 2
Completed NCT02601911 - Effect of Premedication on Success of Inferior Alveolar Nerve Block Injection Phase 2
Completed NCT01496846 - Efficacy Study of Articaine Versus Lidocaine as Supplemental Infiltration in Inflamed Molars Phase 4
Withdrawn NCT04040127 - Residual Dental Pulp Tissue and Cord Blood Stem Cells Phase 2
Completed NCT06176378 - A Clinical and Radiographic Evaluation of Low-Level Diode Laser Full Pulpotomy in Vital Permanent Teeth N/A
Recruiting NCT04243733 - MTA vs CEM Pulpotomy in Young Permanent Molars N/A
Recruiting NCT06245161 - Efficacy of Computer Controlled Intraosseous Anesthesia in Pediatric Dental Patients N/A
Not yet recruiting NCT04573374 - Comparing the Outcome of Pulpotomy Using Biodentine and Portland Cement in Mature Cases With Irreversible Pulpitis: Randomized Clinical Trial N/A
Completed NCT05778227 - Comparing Different Single and Combination Chelating Agents on Sealer Penetration and Dentin Erosion. N/A
Completed NCT04654845 - Patient Perception Between Two Emergency Treatments of Symptomatic Irreversible Pulpitis. N/A
Recruiting NCT06142799 - Influence of Moment of Restoration in Pain After a Root Canal Treatment N/A
Active, not recruiting NCT06240130 - Outcome Following Use of NaOCl and Chlorhexidine as Wound Lavage Agents N/A
Recruiting NCT06149845 - Pulpotomy in Vital Primary Molars Diagnosed With Symptomatic Irreversible Pulpitis N/A
Completed NCT01561183 - Vital Pulp Therapy (VPT) Using Calcium Enriched Mixture (CEM) to Treat Irreversible Pulpitis N/A
Not yet recruiting NCT05277246 - Effect of Using Different Concentrations of NaOCI on IL-8 Level N/A
Completed NCT06081335 - Can Instrumentation Kinematics Affect Post Operative Pain and Substance P Levels? A Randomized Controlled Trial N/A
Recruiting NCT06194721 - The Effect of Intra-pulpal Anesthesia With Cryotherapy on Intra-operative Pain N/A
Recruiting NCT06194773 - The Effect of Totalfil and Neosealer Sealers on the Post-endodontic Pain N/A